SLShiyu Liu

Shiyu Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shiyu Liu has a total of 230 co-authors. Here are the top co-authors by number of shared publications:

  • Siying Liu

    State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration National Clinical Research Center for Oral Diseases Shaanxi Key Laboratory of Stomatology Department of Oral Biology & Clinic of Oral Rare Diseases and Genetic Disease School of Stomatology The Fourth Military Medical University Xi'an Shaanxi China

    18 shared publications
  • Lili Bao

    State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Key Laboratory of Stomatology, Department of Oral Biology, School of Stomatology, The Fourth Military Medical University, Xi'an, China

    15 shared publications
  • Feng Ding

    13 shared publications
  • Yan Jin

    State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi International Joint Research Center for Oral Disease, Center for Tissue Engineering, School of Stomatology, The Fourth Military Medical University, Xi’an, China

    13 shared publications
  • Geng Dou

    State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration National Clinical Research Center for Oral Diseases Shaanxi Key Laboratory of Stomatology Department of Oral Biology & Clinic of Oral Rare Diseases and Genetic Disease School of Stomatology The Fourth Military Medical University Xi'an Shaanxi China

    12 shared publications
  • Xiaoshan Yang

    State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Key Laboratory of Stomatology, Department of Oral Biology & Clinic of Oral Rare Diseases and Genetic Disease, School of Stomatology The Fourth Military Medical University Xi'an Shaanxi China

    10 shared publications

Latest Publications

  • NET‐Inhibiting Bio‐Orthogonal Gelated Neutrophils Reverse Maladaptive Trained Immunity and Protect Against Periodontitis Recurrence

    by Fang Li, Xuan Li, Jin‐Feng Xu, Wen‐Jie Zhang, Hong‐Yu Wang, Jia‐Ming Bi, Mei Xu, Yi Tian, Shi‐Yu Liu, Nan Jia, et al.

    Maladaptive trained immunity (MTI) establishes pathogenic innate immune memory that amplifies the immune response to recurrent chronic inflammatory diseases such as periodontitis, but erasing this memory remains challenging. In this study, we identified neutrophil extracellular traps (NETs) as key mediators of periodontitis‐induced MTI that reprogrammed bone marrow epigenetics and transcriptomics to amplify inflammation upon secondary challenge. Thus, we designed a NET‐inhibiting bioengineered platform (tPA@AGNs‐DNase I) to erase MTI and prevent recurrent inflammation. This platform was constructed by encapsulating tPA within activated gelated neutrophils (AGNs) and conjugating DNase I onto the surface by glycoengineering and click chemistry. Leveraging the inflammation‐homing property of AGNs, the platform enabled co‐delivery of two enzymes: DNase I degraded the DNA scaffold of NETs, while tPA disrupted fibrin‒neutrophil engagement to block NETosis, thereby achieving synergistic NET clearance. Local periodontal administration of tPA@AGNs‐DNase I not only resolved primary inflammation but also reversed established MTI by restoring aberrant bone marrow epigenetic and transcriptional reprogramming, thereby markedly attenuating recurrent hyperinflammation and alveolar bone loss in a religature‐induced periodontitis model. Collectively, this work provides a bioengineered platform that erases central MTI via in situ NET clearance, offering a paradigm‐shifting strategy to control chronic inflammatory disease recurrence.

  • Open Access

    Magnesium Enhances Immune Clearance of P. gingivalis in Macrophages by Suppressing MCU ‐Mediated Mitochondrial Calcium Overload

    by Dao‐Kun Deng, Meng‐Jie Su, Min‐Yi Zhang, Yu‐Jie Tan, Wenyao Kongling, Hong‐Yu Wang, Mei Xu, Shi‐Yu Liu, Xiao‐Tao He, Fa‐Ming Chen, et al.

    P. gingivalis , a keystone periodontal pathogen in periodontitis, is recognized for its capacity to evade host immune clearance. Its intracellular survival leads to both local and systemic infection, thereby increasing the risk of periodontitis and its associated systemic diseases. However, macrophages have limited capacity to clear P. gingivalis , which contributes to disease establishment and progression. Our findings confirmed P. gingivalis presence in periodontitis tissue, with intracellular P. gingivalis mainly located in macrophages. However, P. gingivalis cannot be completely cleared by macrophages and enters the blood circulation through damaged periodontal tissue, leading to systemic infection. Transcriptomic analysis identified mitochondrial calcium uniporter (MCU) as a potential key molecule associated with P. gingivalis immune evasion in macrophages. In vitro functional analyses further confirmed that P. gingivalis infection increased MCU expression and led to both cytosolic and mitochondrial calcium overload, thereby impairing intracellular P. gingivalis clearance in macrophages. Notably, as a natural calcium antagonist, magnesium could inhibit the MCU pathway, reverse calcium overload, and enhance the macrophage‐mediated P. gingivalis clearance. Local administration of magnesium‐containing alginate methacryloyl (AlgMA) hydrogel significantly reduced both local and systemic P. gingivalis infection, relieved inflammation, and alleviated periodontal tissue destruction. Collectively, our findings identify MCU‐mediated calcium overload as a previously unrecognized mechanism by which P. gingivalis evades macrophage immune clearance. Moreover, magnesium‐mediated restoration of Ca 2+ homeostasis offers a promising host‐directed immunomodulatory therapy for periodontitis and other infectious diseases.

  • Open Access

    Pyroptosis‐Amplified Decoy Nanovesicles Orchestrate Pyroptotic Antigen Explosion and Endogenous Immune Revitalization for Potentiating Tumour Immunotherapy

    by Geng Dou, Jiani Liu, Ran Tian, Keying Zhang, Meng Suo, Ding Zhou, Yipeng Zhang, Xuemei Liu, Xinyu Qiu, Jinxin Kuang, et al.

    Current advances in tumour immunotherapy remain constrained by inadequate cytotoxic T lymphocyte activation and the immunosuppressive tumour microenvironment. Innovative strategies are urgently required to enhance anti‐tumour immune potency for clinical improvements in immunotherapy‐resistant malignancies. Herein, we developed pyroptosis‐amplified decoy nanovesicles (PADVs) to synergistically dismantle tumour resistance mechanisms and rejuvenate endogenous anti‐tumour immunity. PADVs integrate checkpoint‐neutralizing capability with precise regulation of the pyroptosis molecular switch in tumour cells, thereby initiating a sequential activation cascade that enables efficient presentation of tumour‐specific antigens to the reshaped immune system. Systemically infused PADVs demonstrated dual‐targeting priority towards lymph node and deep tumour tissues, reversing immunosuppression through competitive blockade of PD‐1/PD‐L1 and SIRPα/CD47 axes while providing co‐stimulatory signals for immune reactivation. Furthermore, PADVs alleviate the epigenetic suppression of pyroptosis in tumours via cytosolic delivery of decitabine and LPS, enabling gasdermin D (GSDMD) upregulation and cleavage. This coordinated strategy reverses T cell exhaustion and triggers explosive antigen release via GSDMD‐mediated membrane perforation, initiating a self‐amplifying immune cascade involving dendritic cell activation, effector and memory T cell formation. Consequently, PADVs demonstrate excellent efficacy in suppressing tumour progression, recurrence, and metastasis in melanoma, breast cancer, and colon cancer models. This study pioneers a versatile nanoplatform that not only counteracts tumour immune evasion but also establishes durable anti‐tumour immunity, offering a transformative approach to tumour immunotherapy.

  • Open Access

    Pulpal Pressure Aggravates Pulpitis by Mechano-Inflammatory Signal Synergy

    by Weiqi Hu, Hao Cui, Yajing Fu, Xinghong Luo, Lan Li, Zhengyan Wang, Lili Bao, Shengkai Gong, Haotian Luo, Siying Liu, et al.

  • Open Access

    Extracellular Vesicles Coordinate Bacterial Cloaking in Lung Epithelial Cells to Alleviate Acute Inflammatory Injury

    by Feng Ding, Shengkai Gong, Haotian Luo, Dandan Wu, Xiaoshan Yang, Zihan Li, Dingmei Zhang, Peijie He, Jiani Liu, Lili Bao, et al.

    The capacity of host professional phagocytes to attenuate excessive inflammatory responses through pathogen cloaking during infection has been well‐established. However, the involvement of non‐professional phagocytes in this process remains unknown. Here, we identify a previously unrecognized mechanism by which lung epithelial cells (LECs) attenuate inflammatory responses during Staphylococcus aureus infection. S. aureus ‐challenged LECs rapidly shed extracellular vesicles (EVs) carrying surface receptors capable of binding invading bacteria and forming EV‐bacteria complexes. The EV‐bacteria complexes were internalized by LECs via RhoA‐ROCK1‐actin‐driven endocytosis pathway, reducing free bacterial burden within the alveolar lumen. This EV‐mediated pathogen cloaking conferred acute‐phase protection, as demonstrated by mitigating early‐stage pulmonary inflammation, and improving survival rates in infected mice. Paradoxically, this strategy permitted chronic bacterial persistence and sustaining low‐grade inflammation. Our findings delineate a trade‐off mechanism that non‐professional phagocytes modulate acute bacterial infection and inflammatory responses via pathogen cloaking. This mechanistic perspective reframes non‐professional phagocytes as active architects of infection outcomes based on EV‐mediated host‐pathogen interactions. Our work provides insights into the mechanism of bacterial cloaking during infection and suggests stage‐specific therapeutic strategies.

  • Rothia mucilaginosa membrane vesicles stabilize labile iron to alleviate UVB-induced ferroptosis

    by Siyuan Fan, Xinyue Cai, Weiqi Wang, Meiling Wu, Xiaoyao Huang, Feng Ding, Hao Guo, Geng Dou, Haotian Luo, Shuai Shao, et al.


  • Open Access

    Branched-chain amino acids contribute to diabetic kidney disease progression via PKM2-mediated podocyte metabolic reprogramming and apoptosis

    by Huishou Zhao, Dan Sun, Shan Wang, Yi Liu, Xiaojuan Zhao, Wenqi Tian, Xiuhong Dou, Jilong Liu, Jinyang Xu, Lu Peng, et al.

    Approximately 30-40% of patients with diabetes develop diabetic kidney disease (DKD). Identifying decisive factors for DKD initiation is crucial. Here, we observed that glomerular podocytes in male and female patients with DKD and db/db mice specifically displayed BCAA catabolic defects. Podocyte-specific PP2Cm (a key BCAA catabolism enzyme) knockout or exogenous BCAA supplementation induced DKD phenotypes including podocyte dysfunction/apoptosis, glomerular pathology, and proteinuria in high-fat (HF)-diet-fed male mice. Mechanistically, BCAAs promoted PKM2 depolymerization and inactivation in podocytes. Depolymerized PKM2 suppressed glucose oxidative phosphorylation (OXPHOS), diverting glucose metabolism towards serine biosynthesis and folate metabolism. Depolymerized PKM2 is also co-transported with DDIT3 into the nucleus, acting as a co-transcriptional factor to enhance DDIT3 transcriptional activity, which promotes Chac1 and Trib3 expression and directly inducing podocyte apoptosis. Thus, BCAA catabolic defects may be one of the missing factors that determine DKD initiation. Targeting BCAA catabolism or PKM2 activation is a promising DKD prevention strategy.


  • Open Access

    Cellular Adaptation to Mechanical Stress Emerges via Cell Shrinkage Triggered by Nonlinear Calcium Elevation

    by Zhengyan Wang, Zihan Li, Lei Wang, Haitao Zhang, Xiaoshan Yang, Lili Bao, Geng Dou, Lili Ren, Yajing Fu, Lan Li, et al.

    Organisms constantly encounter unpredictable environmental perturbations, necessitating adaptation to maintain homeostasis. However, the fundamental principles by which organisms identify specific cues and transition to an adaptive state remain unclear. Here, using a mouse mechanical ventilation model and a cell stretch model, it is found that the cellular adaptation to mechanical stress can be induced by applying low amplitude stretches to cells, and demonstrate that the adaptation emerges once a defined stretch threshold is reached. This adaptive state is marked by transient cell shrinkage and reduced membrane tension. Mechanistically, guided by a mathematical model of intracellular Ca 2+ dynamics, it is found that when stretch reaches a critical amplitude, it induces Ca 2+ ‐dependent positive feedback, leading to nonlinear Ca 2+ elevation. This activates scramblase Anoctamin‐6, promoting extracellular vesicle‐mediated membrane cholesterol efflux. The reduction in membrane cholesterol subsequently activates volume‐regulated anion channels, leading to cell shrinkage and the establishment of mechanical adaptation. These findings reveal a threshold‐dependent mechanism for mechanical adaptation emergence, and propose a promising strategy to develop targeted interventions in mechanical stress‐related disorders.


  • Open Access

    Lipid metabolism of apoptotic vesicles accelerates cutaneous wound healing by modulating macrophage function

    by Yuan Qin, Xin Chen, Lili Bao, Lili Ren, Geng Dou, Jianing Lian, Shujuan Xing, Zihan Li, Feng Ding, Wen Qin, et al.

    The application of apoptotic extracellular vesicles (ApoEVs) derived from stem cell in skin wound healing has garnered significant attention. In recent decades, scholars have shown that extracellular vesicles (EVs) established intercellular communication by carrying proteins or microRNAs, the role of lipids in EVs in wound healing has yet to be clarified. Here, we focus on the key role of group X secretory phospholipase A2 (sPLA2-X) in lipid metabolism. Specifically, sPLA2-X significantly increased the production of the anti-inflammatory lipid mediators, resolvin D5 (RvD5), by hydrolyzing phospholipids in ApoEVs. This change not only promoted the uptake of ApoEVs by macrophages, but also effectively inhibited the expression of tumor necrosis factor-alpha (TNF-α) in macrophages, promoting the healing of skin wounds. In summary, this study contributes to our understanding of the mechanisms by which ApoEVs support skin defect repair and offers a potential theoretical approach for using ApoEVs in skin wound treatment. With further research and optimization, it is expected that more efficient and secure ApoEVs-based treatment strategies will be developed, bringing new breakthroughs in clinical treatment of skin injuries and related diseases.


  • Open Access

    T Cell-Derived Apoptotic Extracellular Vesicles Ameliorate Bone Loss via CD39 and CD73-Mediated ATP Hydrolysis

    by Xiaoshan Yang, Yang Zhou, Fuxing Zhou, Lili Bao, Zhengyan Wang, Zihan Li, Feng Ding, Huijuan Kuang, Huan Liu, Shenglong Tan, et al.

    Background: Osteoporosis is a major public health concern characterized by decreased bone density. Among various therapeutic strategies, apoptotic extracellular vesicles (ApoEVs) have emerged as promising agents in tissue regeneration. Specifically, T cell-derived ApoEVs have shown substantial potential in facilitating bone regeneration. However, it remains unclear whether ApoEVs can promote bone mass recovery through enzymatic activity mediated by membrane surface molecules. Therefore, this study aimed to investigate whether T cell-derived ApoEVs could promote bone mass recovery in osteoporosis mice and reveal the underlying mechanisms. Methods: ApoEVs were isolated through sequential centrifugation, and their proteomic profiles were identified via mass spectrometry. Western blot and immunogold staining confirmed the enrichment of CD39 and CD73 on ApoEVs. The role of CD39 and CD73 in hydrolyzing adenosine triphosphate (ATP) to adenosine was evaluated by quantifying the levels of ATP and adenosine. Inhibitors of CD39 and CD73, and an A2BR antagonist were used to explore the molecular mechanism of ApoEVs in promoting bone regeneration. Results: ApoEVs significantly reduced bone loss and promote the osteogenic differentiation of BMMSCs in ovariectomy (OVX) mice. We observed increased levels of extracellular ATP and a decrease in CD39 and CD73, key enzymes in ATP-to-adenosine conversion in bone marrow of OVX mice. We found that ApoEVs are enriched with CD39 and CD73 on their membranes, which enable the hydrolysis of extracellular ATP to adenosine both in vitro and in vivo. The adenosine generated by ApoEVs inhibits the inflammatory response and promotes osteogenesis through A2BR and downstream PKA signaling. Conclusion: T cell-derived ApoEVs are enriched with CD39 and CD73, enabling them to hydrolyze extracellular ATP to adenosine, thereby promoting bone regeneration via A2BR and PKA signaling pathway. Our data underscore the substantive role of T cell-derived ApoEVs to treat osteoporosis, thus providing new ideas for the development of ApoEVs-based therapies in tissue regeneration.